baber/WOPTO huggingface dataset:
Patent CA-3111553-A1 (CA)
Inventor: LIMAYE AMIT UDAY
IPC: A61M5/34
Filed: 2012-04-20
Abstract: ABSTRACT Disclosed is a safety pen needle assembly including a hub, a needle fixed to a transverse wall of the hub, and a shield formed to at least partially telescope over the hub. An outer ablumenal surface of the hub and an inner lumenal surface of the shield are formed with cooperating thread elements to permit relative rotation between the hub and the shield. Initially, the shield and the hub are configured with a rotation-resistance arrangement which inhibits relative rotation between the hub and the shield. This arrangement is surmountable to allow relative rotation between the hub and the shield with an at least threshold amount of torque being applied. Advantageously, a safety pen needle assembly can be provided having a shield threaded onto a hub with the assembly being mountable with the needle being in a shielded state, to avoid needle sticks during mounting of the safety pen needle assembly. Date Recue/Date Received 2021-03-09
Patent CA-3113682-A1 (CA)
Title: Methods of preparing and analyzing nucleic acid libraries
Inventor: KAMBEROV EMMANUEL
IPC: C12Q1/686
Filed: 2020-02-14
Abstract: Detecting different mutations in the same sample is essential, especially where the sample is limited in quantity and where high-throughput methods are desired for rapid detection of mutations. Methods routinely used in the art require separate assays for detecting different mutations or mutation types (e.g. single nucleotide polymorphisms (SNPs) or copy number variations (CNVs)) in a sample. The present disclosure provides methods for detecting different mutations, such as SNPs and CNVs in the same sample. The methods described herein can be useful in preimplantation genetic testing, carrier screening, or genotyping
Patent CA-3117071-A1 (CA)
Inventor: SIDELMANN CHRISTENSEN TOBIAS
IPC: A61K33/26
Filed: 2019-10-29
Abstract: The present invention relates to the field of treating iron deficiency with IV iron carbohydrate complexes such ferric carboxymaltose, monitoring or identifying subjects to determine their eligibility for being administered said IV iron carbohydrate complexes, and combining said IV iron carbohydrate complexes with additional drugs in order to mitigate or reduce side effects induced by said IV iron carbohydrate complexes.
Patent CA-3118303-A1 (CA)
Inventor: IYENGAR SRIDHAR
IPC: F25D21/00
Filed: 2019-11-04
Abstract: A method for determining a time frame for when a freezer having a compressor should be defrosted include the steps of measuring compressor cycling over time, determining a change in compressor cycling over time, and determining from the change in in compressor cycling over time determined a time frame for when the freezer should be defrosted.
Patent CA-3118643-A1 (CA)
Inventor: LICHTENBERG ARI
IPC: B65C9/00
Filed: 2021-05-14
Abstract: Un dispositif pour retirer les étiquettes dun applicateur détiquettes dans un système détiquetage de produits est décrit. Le dispositif comprend un rouleau de ramassage détiquettes situé sur le chemin en aval de lapplicateur. Une tige est positionnée sur la machine, de sorte que le rouleau puisse être positionné tel que déterminé. Lorsquune étiquette posée sur un produit par lapplicateur nest pas appliquée pour une raison ou une autre, le rouleau de ramassage retire cette étiquette non appliquée de lapplicateur avant que lapplicateur retourne au distributeur détiquettes pour recevoir une nouvelle étiquette pour le prochain cycle détiquetage.
Patent CA-3118835-A1 (CA)
Title: Computerized systems and methods for golf course management
Inventor: GARSIDE TYLER
IPC: G06Q30/00
Filed: 2021-05-17
Abstract: Systems and methods for golf course tee time booking, score tracking, and customer relationship management are disclosed in near real-time. The system may be used for administering a loyalty program whereby loyalty points are earned and automatically redeemable for future purchases at golf courses, and for providing rate integrity. For example, the price in dollars for a deal (and the associated fees and taxes) is automatically converted into a point value which is displayed as the purchase price for the deal instead of the dollar amount. The system may be used for automated score tracking for individual rounds of golf, tournaments or leagues. The disclosed system can agglomerate tee time booking and score tracking for individual golf courses or associations of affiliated courses thereby providing customers with a centralized booking system and loyalty program.
Patent CA-3119947-A1 (CA)
Inventor: KUBO YOHEI
IPC: H02J15/00
Filed: 2019-11-20
Abstract: This compressed air storage power generation device (10) is provided with electric motors (2a-2d), compressors (3a-3d), pressure accumulator units (6a, 6b), expanders (5a-5d), power generators (4a-4d), and a control unit (15). The compressors (3a-3d) include dynamic first compressors (3b-3d) and a positive displacement second compressor (3a). The expanders (5a-5d) include dynamic first expanders (5b-5d) and a positive displacement second expander (5a). During charging of the compressed air storage power generation device (10), when the fluctuation time of an estimated fluctuating power exceeds the start/stop time of the first compressors (3b-3d), the control unit (15) deals with the portion of the estimated fluctuating power by controlling the number of the first compressors (3b-3d) and controlling the number of and the rotational speed of the second compressor (3a). When the fluctuation time of the estimated fluctuating power is less than or equal to the start/stop time of the first compressors (3b-3d), the control unit (15) performs control so as to deal with the portion of the estimated fluctuating power by controlling the number of and the rotational speed of the second compressor (3a). Additionally/alternatively, during discharging of the compressed air storage power generation device (10), when the fluctuation time of the estimated fluctuating power exceeds the start/stop time of the first expanders (5b-5d), the control unit (15) deals with the portion of the estimated fluctuating power by controlling the number of the first expanders (5b-5d) and controlling the number of and the rotational speed of the second expander (5a). When the fluctuation time of the estimated fluctuating power is less than or equal to the start/stop time of the first expanders (5b-5d), the control unit (15) performs control so as to deal with the portion of the estimated fluctuating power by controlling the number of and the rotational speed of the second expander (5a).
Patent CA-3119975-A1 (CA)
Inventor: Rider Michael
IPC: B67D1/04
Filed: 2019-11-20
Abstract: Devices and methods for dispensing beverage from a container (700), such as a wine bottle, using a dispensing device (1). The device (1) may automatically purge at least one conduit (200) used to deliver gas to a beverage container (700) or to carry beverage from the beverage container in response to detecting that a dispensing operation is about to begin, or in response to detecting that a dispensing operation is complete. Visual or other displays (51) may be provided to the user to indicate that the device (1) is ready for use in dispensing, that a conduit is in fluid communication with the container interior and/or that the device is controlling components to dispense beverage.
Patent CA-3120430-A1 (CA)
Title: Six-membered fused with six-membered heterocyclic compound and uses thereof serving as protein receptor kinase inhibitor
Inventor: JIANG LEI
IPC: A61P35/00
Filed: 2019-11-13
Abstract: Provided are a preparation and applications of a six-membered and six-membered heterocyclic compound, specifically, provided in the present invention is a compound as represented by formula I as follows, where the definitions of the groups are as described in the description. The compound has TRK kinase inhibiting activity and can serve as a pharmaceutical composition for treating TRK dysfunction-related diseases. (I)
Patent CA-3122881-A1 (CA)
Inventor: WILD ANDREAS
IPC: H01M4/1399
Filed: 2019-11-07
Abstract: The present invention relates to a process for producing a charge storage unit, especially a secondary battery, the electrodes of which comprise an organic redox-active polymer, and which includes a polymeric solid electrolyte. The solid electrolyte is obtained by polymerizing from mixtures of acrylates with methacrylates in the presence of at least one ionic liquid, which imparts advantageous properties to the charge storage unit. The present invention additionally also relates to the charge storage unit itself.
Patent CA-3123611-A1 (CA)
Title: Using natural language processing to find adverse events
Inventor: LIU CHEN
IPC: G16H15/00
Filed: 2019-12-20
Abstract: A method for automatically classify ing clinical descriptions of patients by a computer processor using natural language processing is provided. The clinical descriptions relate to the use of a ventricular assist device to treat the patient. The method comprises receiving at least one clinical description comprising text. The method also then comprises determining the position of a target word within the text. Further the method comprises determining the existence of at least one negation word within an active region, the active region comprising a predetermined number of words within the text occurring immediately before and immediately after the target word, including the target word. The method then comprises determining the existence of at least one body-part word within the active region. Lastly, the method comprises determining that the clinical description is to be disregarded if the active region contains either a negation word or a body-part word.
Patent CA-3124193-A1 (CA)
Title: Method for the prevention of mist formation in a device comprising rolls during the coating of flexible supports with a cross-linkable liquid silicone composition
Inventor: PIBRE GUILLAUME
IPC: C09D183/06
Filed: 2019-12-19
Abstract: The invention relates to the general field of coating various flexible supports, such as sheets of paper or synthetic polymer (polyolefin, polyester, etc) sheets or fabric sheets, with a silicone on high-speed rolls. The invention relates to an efficient method for preventing mist formation when coating flexible supports with a liquid silicone composition precursor of cross-linked coatings, said coating process being performed using a coating device that includes a roll operating at a high speed.
Patent CA-3124566-A1 (CA)
Title: Thermally inhibited starch and process for making
Inventor: SHAH TARAK
IPC: C08B30/12
Filed: 2019-12-27
Abstract: Improved thermally inhibited starch is disclosed and methods of making such starch are disclosed. In some embodiments a thermally inhibited starch has improved whiteness and flavor. In some embodiments a method for making a thermally inhibited starch includes providing adding a buffer and an acid to a starch to obtain a pH adjusted starch having an acidic pH and thermally inhibiting the pH adjusted starch. The technology further pertains to methods of making the thermally inhibited starch in batch, continuous, continuous-like process or combinations thereof.
Patent CA-3126267-A1 (CA)
Title: Device for winding a flexible tube
Inventor: KANDIN PATRICE
IPC: B65H75/36
Filed: 2020-01-10
Abstract: The invention relates to a device for winding a flexible tube comprising two blades LAM that are coupled in rotation about a pivoting axis PIVO appearing at the left-hand end of these blades. The device is defined such that: - a blade LAM has, on its left-hand edge, a first notch En1 which is open at the top and which is formed by a first arc of a circle Ac1 whose origin is a connection point P2 located on the right-hand edge of this notch and on the longitudinal axis AXL of this device, - the blade LAM has, on its right-hand edge, a second notch En2 which is open at the top and which is formed by a second arc of a circle Ac2 whose origin is a connection point P4 located on the right-hand edge of this notch and on the longitudinal axis AXL of this device, and - a diameter of these arcs of circles Ac1, Ac2 is supported by the longitudinal axis AXL. Moreover, one of these arcs of a circle (Ac2) has an angle at the centre equal to the sum of 180° and an additional angle (K) greater than 0°.
Patent CA-3128824-A1 (CA)
Title: Prrs viruses, infectious clones, mutants thereof, and methods of use
Inventor: FAABERG KAY S
IPC: C07K14/08
Filed: 2006-06-23
Abstract: The present invention provides isolated infectious polynucleotides, such as infectious clones, having a nucleotide sequence with identity to PRRS viruses such as VR-2332, Lelystad, or others, and optionally further including a deletion in a region of ORFI  that encodes the n5p2 polypeptide.
Patent CA-3132179-A1 (CA)
Inventor: GRIFFIN PATRICK R
IPC: A61K31/535
Filed: 2020-04-03
Abstract: Disclosed herein are methods and uses of the polypharmacological modulator SR1903 and related compounds for inhibiting triggering receptor expressed on myeloid cells-1 (TREM-1) and treating diseases and conditions that are related to or mediated by TREM-1, such as inflammatory diseases, autoimmune diseases, metabolic disorders, and castration resistant prostate cancer (CRPC).
Patent CA-3132231-A1 (CA)
Inventor: LIU XIANG
IPC: H03M13/03
Filed: 2020-04-01
Abstract: A method comprises generating a PON frame comprising a plurality of FEC codewords, the FEC codewords comprise a first codeword, and the first codeword comprises a PSB; and transmitting the PON frame. A method comprises receiving a PON frame comprising a plurality of FEC codewords, the FEC codewords comprise a first codeword, and the first codeword comprises a PSB; and processing the PON frame.
Patent CA-3132928-A1 (CA)
Title: Composition pharmaceutique
Inventor: GOGNIAT GEOFFREY
IPC: A61K9/48
Filed: 2020-03-11
Abstract: La présente invention concerne le domaine de la pharmacie, en particulier une composition pharmaceutique pour une administration orale comprenant (a) un substrat inerte et (b) un mélange comprenant un agoniste du récepteur farnésoïde X (FXR) non acide biliaire, tel que le 2-[(1R,3r,5S)-3-({5-cyclopropyl-3-[2-(trifluorométhoxy)phényl]-1,2-oxazol-4-yl}méthoxy)-8-azabicyclo[3.2.1] octan-8-yl]-4-fluoro-1,3-benzothiazole-6-acide carboxylique, ou un sel pharmaceutiquement acceptable de celui-ci, et au moins un liant. La présente invention concerne également un procédé de préparation de ladite composition pharmaceutique pour une administration orale; et l'utilisation de ladite composition pharmaceutique dans la fabrication d'un médicament.
Patent CA-3133719-A1 (CA)
Title: High velocity steam injection in hydrocarbon containing streams
Inventor: MANESH SEPIDEH MORTAZAVI
IPC: B03D1/08
Filed: 2021-10-08
Abstract: A disclosed method comprises degassing process comprising providing high velocity steam and injecting the high velocity steam directly into bitumen froth such that the steam shears gas bubbles for reducing an amount of air in the bitumen froth. Also disclosed is a solvent recovery process comprising providing high velocity steam and injecting the high velocity steam into tailings in a tailings solvent recovery unit (TSRU) or into a bitumen stream in a solvent recovery unit (SRU) for shearing hydrocarbon laden agglomerates for reducing an amount of solvent in the tailings or in the bitumen stream.
Patent CA-3133865-A1 (CA)
Title: Image signal representing a scene
Inventor: VAN GEEST BARTHOLOMEUS WILHELMUS DAMIANUS
IPC: G06T7/00
Filed: 2020-02-14
Abstract: Generating an image signal comprises a receiver (401) receiving source images representing a scene. A combined image generator (403) generates combined images from the source images. Each combined image is derived from only parts of at least two images of the source images. An evaluator (405) determines prediction quality measures for elements of the source images where the prediction quality measure for an element of a first source image is indicative of a difference between pixel values in the first source image and predicted pixel values for pixels in the element. The predicted pixel values are pixel values resulting from prediction of pixels from the combined images. A determiner (407) determines segments of the source images comprising elements for which the prediction quality measure is indicative of a difference above a threshold. An image signal generator (409) generates an image signal comprising image data representing the combined images and the segments of the source images.
Patent CA-3134834-A1 (CA)
Inventor: HESS HAROLD
IPC: F16B39/282
Filed: 2020-03-30
Abstract: A fastener assembly includes a threaded member including a threaded body portion and a head portion. The fastener assembly also includes a first lock member including a plurality of axially-extending ratchet teeth and defining an aperture extending therethrough. The aperture is sized to receive the threaded body portion. The fastener assembly further includes a second lock member including a base portion configured to couple to the threaded member for rotation therewith and at least one spring finger extending axially from the base portion. The at least one spring finger has a proximal end joined to the base portion and a free end opposite the proximal end. The second lock member has a lock position in which the free end of the at least one spring finger is configured to engage the plurality of axially-extending ratchet teeth and an unlock position in which the free end of the at least one spring finger is spaced from the plurality of axially-extending ratchet teeth.
Patent CA-3136255-A1 (CA)
Inventor: DAVIDSON JAN KENNETH
IPC: A61K39/00
Filed: 2020-04-08
Abstract: The present invention is directed to a dosing regimen for administering a CD 123 x CDS bispecific diabody to patients with a hematologic malignancy such as acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). The present invention is also directed to a dosing regimen for administering a CD 123 x CDS bispecific diabody in combination with a molecule capable of binding PD-1 or a natural ligand of PD-1 (a "PD-1 or PD-1 ligand binding molecule") to patients with a hematologic malignancy such as acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). The invention particularly concerns the use of such regimens for administering the sequence-optimized CD 123 x CDS bispecific diabody, "DART-A," which is capable of simultaneous binding to CD 123 and CDS.
Patent CA-3141442-A1 (CA)
Title: Multi-modal vehicle
Inventor: KARADIA NARENDRA HIRALAL
IPC: B64C39/08
Filed: 2020-05-20
Abstract: The present invention relates to a multi-modal vehicle (2) operable in a first mode as a fixed wing aircraft and reconfigurable to be operable in a second mode as a ground vehicle. The vehicle comprises first (12) and second ends (14) configured to operate in a first direction (6), with the first end leading the second end, in the first mode and in a second direction (10), with the second end (14) leading the first end (12), in normal operation in the second mode.
Patent CA-3144798-A1 (CA)
Title: System and method for parallel implementation of multi-qubit quantum gates
Inventor: PICHLER HANNES
IPC: G06N10/40
Filed: 2020-07-10
Abstract: A device includes a grouping of N qubits, where N is equal to two or more, and a coherent light source configured to, given selected values for a set of parameters of at least a first and a second laser pulse, the parameters selected from a relative phase shift, a laser frequency, a laser intensity, and a pulse duration: apply at least the first and second laser pulses to all qubits within the grouping of N qubits, thereby coupling a non-interacting quantum state |1> to an interacting excited state |r), such that each qubit that begins in quantum state |1) returns to the state |1) upon completion of the at least first and second laser pulses, and such that qubits in the grouping are mutually blockaded.
Patent CA-3145986-A1 (CA)
Inventor: KURI ISABEL
IPC: B65D33/24
Filed: 2020-04-02
Abstract: Systems and methods for a compression pouch with a rear shell and a front shell that are coupled together with a compressible layer, wherein the compressible layer is configured to open and close via a zipper, and a coupling mechanism positioned on the front shell and a flap.
Patent CA-3147982-A1 (CA)
Inventor: QIAN ZHEN
IPC: C08K5/52
Filed: 2019-09-05
Abstract: L'invention concerne une dispersion aqueuse de polymère et une composition aqueuse de revêtement comprenant une telle dispersion aqueuse de polymère qui présente une bonne stabilité F/T et des propriétés anti-colmatage satisfaisantes et fournit des revêtements présentant une bonne résistance aux taches hydrophobes.
Patent CA-3148012-A1 (CA)
Title: Method and process for placement and fixation of a surgical implant
Inventor: RON UDI
IPC: A61N1/36
Filed: 2020-08-26
Abstract: A method of treating obstructive sleep apnea according to this disclosure may include: providing an implant comprising a substantially planar central body portion having a top side and a bottom side; at least two adjustable wing portions; and at least two connecting members, each one of the at least two connecting members extending from opposite sides of the central body portion, the each one of the at least two connecting members being configured for flexibly connecting each one of the at least two wing portions at opposite sides to said central body portion; forming a surgical opening to expose a genioglossus muscle; exposing a branch of a hypoglossal nerve for stimulation by the implant at least on one side of the geniouglossus; forming at least one pocket on at least one side of the geniouglossus; such that the pocket dimensions are configured to fit the at least one of the at least two wing portions of the device; inserting an implant device through the surgical opening such that the central body extends over the genioglossus and each one of the wing portions is received in the respective at least one pocket; and securing the implant device to the muscle.
Patent CA-3148037-A1 (CA)
Title: Use of palmitoylethanolamide for the prevention and/or treatment of covid-19 infections
Inventor: DELLA VALLE FRANCESCO
IPC: A61K31/164
Filed: 2022-02-07
Abstract: The present invention relates to a method of treating a COVID-19 infection by administering an effective amount of an endogenous compound devoid of significant toxicity. In particular, the present invention relates to a method of treating a patient affected by COVID-19 infection comprising administering an effective amount of a mixture of ultra-micronized palmitoylethanolamide and micronized palmitoylethanolamide to said patient.
Patent CA-3148436-A1 (CA)
Inventor: PI SHIQING
IPC: A61P37/06
Filed: 2020-08-19
Abstract: L'invention concerne une application, dans la préparation d'un médicament pour la prévention ou le traitement d'une maladie liée à une tyrosine kinase, d'un composé tel que représenté par la formule I, ou d'un sel, d'un ester, d'un solvate, d'un promédicament, d'un métabolite actif, d'un cristal, d'un stéréoisomère, d'un tautomère ou d'un isomère géométrique pharmaceutiquement acceptable de celui-ci, ou d'une composition pharmaceutique comprenant le composé tel que représenté par la formule I ou le sel, l'ester, le solvate, le promédicament, le métabolite actif, le cristal, le stéréoisomère, le tautomère ou l'isomère géométrique pharmaceutiquement acceptable de celui-ci.